CURE vs. SPXS
CURE (Direxion Daily Healthcare Bull 3x Shares) and SPXS (Direxion Daily S&P 500 Bear 3X Shares) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while SPXS is a Inverse Equities fund tracking the S&P 500 Index (-300%). Both are passively managed. Over the past 10 years, CURE returned 14.03%/yr vs -42.08%/yr for SPXS. At a correlation of -0.70, they often move in opposite directions. Both charge a 1.08% expense ratio.
Performance
CURE vs. SPXS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -10.45% return, which is significantly higher than SPXS's -20.76% return. Over the past 10 years, CURE has outperformed SPXS with an annualized return of 14.03%, while SPXS has yielded a comparatively lower -42.08% annualized return.
CURE
- 1D
- 3.78%
- 1M
- 4.14%
- YTD
- -10.45%
- 6M
- -10.93%
- 1Y
- 35.07%
- 3Y*
- 1.46%
- 5Y*
- 0.46%
- 10Y*
- 14.03%
SPXS
- 1D
- 3.42%
- 1M
- 3.11%
- YTD
- -20.76%
- 6M
- -18.37%
- 1Y
- -44.21%
- 3Y*
- -40.67%
- 5Y*
- -33.53%
- 10Y*
- -42.08%
CURE vs. SPXS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -10.45% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
SPXS Direxion Daily S&P 500 Bear 3X Shares | -20.76% | -41.53% | -42.84% | -45.97% | 36.14% | -58.11% | -70.47% | -56.40% | 3.44% | -44.52% |
Correlation
The correlation between CURE and SPXS is -0.30, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.45 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.57 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.65 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | -0.70 |
Over the past year, the inverse relationship between CURE and SPXS has weakened: their correlation has moved from -0.70 to -0.30, meaning they move in opposite directions less often than they have historically.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. SPXS — Risk / Return Rank
CURE
SPXS
CURE vs. SPXS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily S&P 500 Bear 3X Shares (SPXS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | SPXS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.98 | ||
| Sortino ratioReturn per unit of downside risk | +3.34 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 0.79 | +0.36 |
| Calmar ratioReturn relative to maximum drawdown | 1.13 | -0.94 | +2.08 |
| Martin ratioReturn relative to average drawdown | 2.51 | -1.63 | +4.15 |
Loading charts...
Drawdowns
CURE vs. SPXS - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum SPXS drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for CURE and SPXS.
Loading charts...
Drawdown Indicators
| CURE | SPXS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -100.00% | +30.81% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -46.94% | +15.84% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -84.13% | +32.20% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -90.11% | +37.88% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -99.63% | +30.44% |
Current DrawdownCurrent decline from peak | -28.92% | -100.00% | +71.08% |
Average DrawdownAverage peak-to-trough decline | -18.18% | -96.29% | +78.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.98% | 29.25% | -15.27% |
Volatility
CURE vs. SPXS - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 15.41% compared to Direxion Daily S&P 500 Bear 3X Shares (SPXS) at 14.08%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than SPXS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | SPXS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.41% | 14.08% | +1.33% |
Volatility (6M)Calculated over the trailing 6-month period | 31.09% | 29.38% | +1.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.49% | 37.37% | +7.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.92% | 50.68% | -6.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.58% | 53.59% | -4.01% |
CURE vs. SPXS - Expense Ratio Comparison
Both CURE and SPXS have an expense ratio of 1.08%.
Dividends
CURE vs. SPXS - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.19%, less than SPXS's 4.62% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.19% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
SPXS Direxion Daily S&P 500 Bear 3X Shares | 4.62% | 4.93% | 6.18% | 5.66% | 0.00% | 0.00% | 0.51% | 1.74% | 0.58% | 0.00% |
Frequently Asked Questions
CURE and SPXS have a correlation of -0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (15.41%) compared to SPXS (14.08%). In terms of maximum drawdown, CURE dropped -69.19% vs SPXS's -100.00%.
On 10-year performance, CURE leads with 14.03% vs -42.08% for SPXS. Both ETFs have the same 1.08% expense ratio. On volatility, SPXS has been the lower-risk option at 14.08%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 14.03% return vs -42.08%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CURE and SPXS have the same expense ratio: 1.08% per year.
SPXS has the higher dividend yield at 4.62%, compared with 1.19% for CURE.
CURE is categorized as Leveraged Equities, while SPXS is Inverse Equities. CURE tracks Health Care Select Sector Index (300%), while SPXS tracks S&P 500 Index (-300%).
CURE currently has the higher Sharpe Ratio (0.79 vs -1.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and SPXS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer